Drugs / GSK2197870A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00871338 | Jun 2009 → Mar 2010 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2197870A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00871338 ↗ |
| Modality | Vaccine | “GSK2197870A vaccine” NCT00871338 ↗ |
| Route | Intramuscular | “All vaccines were administered intramuscularly.” NCT00871338 ↗ |